Source: Annual Congress 2010 - Various aspects of respiratory epidemiology
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Wood, P. Newby, L. Harper, R. Stockley (Birmingham, United Kingdom). Classical ANCA subtypes are uncommon and do not relate to clinical phenotype in AATD. Eur Respir J 2010; 36: Suppl. 54, 4686

Member's Comments

No comment yet.

Related content which might interest you: Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype Source: Eur Respir J, 56 (6) 2001205; 10.1183/13993003.01205-2020 Year: 2020 Interstitial pneumonia with autoimmune features associated with myositis autoantibodies: clinical characteristics from a multicenter Latin-American cohort. Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Clinical features of dermatitis, myositis and severe ILD. Could the  AntiSSA / Ro52 antibodies be a diagnostic and prognostic tool for Antisyntatase syndrom? Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020 Rare manifestations of AATD Source: Eur Respir Monogr 2019; 85: 127-142 Year: 2019 Clinical features of patients with sarcoidosis associated with Sjogren‘s syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 32s Year: 2005 Clinical manifestations of selective IgA immunodeficiency in childhood Source: Eur Respir J 2002; 20: Suppl. 38, 193s Year: 2002 The prevalence and subtypes of interstitial lung disease in polymyositis and dermatomyositis patients Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Different clinical suspect that brings to the diagnosis of alpha1-antitrypsin deficiency Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Variants of the clinical course of familial pulmonary sarcoidosis Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Interstitial pneumonia with autoimmune features (IPAF): the relationship between radiological and clinical features Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 The clinical and genetic features of COPD-asthma overlap syndrome Source: Eur Respir J 2014; 44: 341-350 Year: 2014 IPF: a distinct clinical entity? Source: International Congress 2017 – State of the art session: "Interstitial lung disease and pulmonary vascular diseases" Year: 2017 a1-antitrypsin PI*SZ genotype: a SERPINA1 deficiency haplotype with uncertain clinical and therapeutic implications Source: Eur Respir J, 55 (6) 2000713; 10.1183/13993003.00713-2020 Year: 2020 Clinicopathological features in thymoma-associated autoimmune disease Source: Eur Respir J 2005; 26: Suppl. 49, 435s Year: 2005 Castleman disease variant of atypical POEMS syndrome: A case presentatIon Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients Source: Eur Respir J 2015; 46: 197-206 Year: 2015 Gene variants and clinical course of pulmonary sarcoidosis in a Slavic population Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017 Clinical features and outcomes of patients with myositis associated-interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021